Prevail Therapeutics (PRVL) Q4 2020 Earnings

25MarExpected
May 20
Aug 20
Nov 20
Q4 2020
-0.66
-0.6
-0.54
-0.48

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Prevail Therapeutics (PRVL) will report earnings of for Q4 2020 on March 25, 2021.

0 Comments

Share your thoughts